Sign In
Buy BUD
$79.04
-1.54 (-1.91%)
At Close: Jun 03, 2026
10.6 Billion Reasons to Buy This Ultra-High Dividend Stock
02:07pm, Saturday, 13'th Aug 2022 The Motley Fool
Not selling this multi-billion dollar stake could pay off big.
10.6 Billion Reasons to Buy This Ultra-High Dividend Stock
10:07am, Saturday, 13'th Aug 2022
Not selling this multi-billion dollar stake could pay off big.
Is Altria a Buy?
02:15pm, Tuesday, 09'th Aug 2022 The Motley Fool
The tobacco giant has been beaten down after a series of misfortunes.
Top Research Reports for Amazon.com, Berkshire Hathaway & Thermo Fisher
06:58pm, Monday, 01'st Aug 2022 Zacks Investment Research
Today's Research Daily features new research reports on 16 major stocks, including Amazon.com, Inc. (AMZN), Berkshire Hathaway Inc. (BRK.B) and Thermo Fisher Scientific Inc. (TMO).
This Healthcare Stock Tumbled 43%; Here Are 88 Biggest Movers From Yesterday
09:55am, Friday, 29'th Jul 2022 Benzinga
Gainers
Athersys, Inc. (NASDAQ: ATHX) climbed 71.1% to close at $0.3250 on Thursday after gaining 10% on Wednesday. Athersys is expected to release its Q2 financial results on Thursday, August 11, 20
AB InBev CEO Michel Doukeris on earnings, beer demand and inflation
08:36am, Friday, 29'th Jul 2022
AB InBev CEO Michel Doukeris joins CNBC's 'Squawk Box' to react to the company's second-quarter earnings report. Doukeris also discusses how demand for beer has shifted following the Covid-19 pandemic
Anheuser-Busch InBev NV (BUD) Q2 2022 Earnings Call Transcript
06:00pm, Thursday, 28'th Jul 2022 The Motley Fool
BUD earnings call for the period ending June 30, 2022.
Why Shares of Solar Companies Are Trading Higher? 64 Stocks Moving In Thursday's Mid-Day Session
04:41pm, Thursday, 28'th Jul 2022 Benzinga
Gainers
Petros Pharmaceuticals, Inc. (NASDAQ: PTPI) gained 231% to $2.63 on news that the company will be acquired By Henry Crown and Company for $3.25 per share. Petros Pharmaceuticals, however, con
Meta, Charter Communications, Southwest Airlines And Some Other Big Stocks Moving Lower On Thursday
03:45pm, Thursday, 28'th Jul 2022 Benzinga
Bausch Health Companies Inc. (NYSE: BHC) shares fell 50.3% to $4.3166 following reports of an order on a patent litigation over Xifaxan.
Pathward Financial, Inc. (NASDAQ: CASH) fell 25.2% to $32.26
AB InBev (BUD) Q2 Earnings Beat Estimates, Revenues Miss
01:11pm, Thursday, 28'th Jul 2022 Zacks Investment Research
AB InBev's (BUD) Q2 results reflect gains from investment in brands, the robust execution of strategies and growth in the digital business. Supply-chain woes continue to mar margins.
Anheuser-Busch Inbev SA (BUD) CEO Michel Doukeris on Q2 2022 Results - Earnings Call Transcript
12:42pm, Thursday, 28'th Jul 2022
Anheuser-Busch Inbev SA (BUD) Q2 2022 Earnings Conference Call July 28, 2022 9:00 AM ET Company Participants Michel Doukeris - CEO Fernando Tennenbaum - CFO Conference Call Participants Simon Hales -
AB InBev (BUD) Q2 Earnings Beat Estimates, Revenues Miss
10:58am, Thursday, 28'th Jul 2022
AB InBev's (BUD) Q2 results reflect gains from investment in brands, the robust execution of strategies and growth in the digital business. Supply-chain woes continue to mar margins.
Why Meta Platforms Is Trading Lower By More Than 6%: Here Are 34 Stocks Moving Premarket
10:09am, Thursday, 28'th Jul 2022 Benzinga
Gainers
JAKKS Pacific, Inc. (NASDAQ: JAKK) rose 34.7% to $23.01 in pre-market trading after the company reported better-than-expected Q2 results.
Athersys, Inc. (NASDAQ: ATHX) rose 35.1% to $0.2568 i
AB InBev reports higher than expected Q2 earnings
01:22am, Thursday, 28'th Jul 2022
Anheuser-Busch InBev, the world's largest brewer, on Thursday reported higher than expected second-quarter earnings as consumers drank more and paid higher prices for its beers.
